Ikarian Capital, LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 48 filers reported holding REGULUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$384,000
-1.0%
1,289,130
+4.9%
0.05%
-13.8%
Q4 2021$388,000
-54.3%
1,228,4160.0%0.06%
-3.3%
Q3 2021$849,000
-16.3%
1,228,416
-1.4%
0.06%
-26.8%
Q2 2021$1,014,000
-47.8%
1,245,9890.0%0.08%
+26.2%
Q1 2021$1,943,0001,245,9890.06%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,851,851$951,0000.11%
BVF INC/IL 3,217,480$1,654,0000.09%
NEA Management Company, LLC 2,052,455$1,055,0000.04%
McGuire Investment Group, LLC 24,000$12,0000.00%
WEDBUSH SECURITIES INC 70,204$36,0000.00%
GRIMES & COMPANY, INC. 23,998$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,200$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 64,347$33,0000.00%
MILLENNIUM MANAGEMENT LLC 49,497$25,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders